Corteva Q1 revenue beats analyst estimates on higher volumes

Overview

• Global agriculture company's Q1 revenue grew 11% yr/yr, beating analyst expectations

• Adjusted EPS for Q1 rose 33% yr/yr

• Company plans to repurchase $500 mln of shares in first half of 2026

Outlook

• Corteva reaffirms 2026 operating EBITDA guidance of $4.0 bln to $4.2 bln

• Company expects 2026 operating EPS of $3.45 to $3.70

• Corteva anticipates resilient demand and manageable impact from geopolitical and trade developments

Result Drivers

• SEED VOLUME AND MIX - Seed sales rose on higher volumes, improved product mix, and favorable currency, with North America and EMEA gains driven by timing shifts and favorable weather

• CROP PROTECTION VOLUME - Crop Protection sales increased on higher volumes from new products and spinosyns, though price declined in Latin America and APAC due to competition

• PRODUCTIVITY AND COST INITIATIVES - Ongoing productivity and cost initiatives supported margin expansion across both businesses

Company press release: ID:nPn6TVD08a

Key Details

Analyst Coverage

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 17 "strong buy" or "buy", 7 "hold" and no "sell" or "strong sell"

• The average consensus recommendation for the agricultural chemicals peer group is "buy"

• Wall Street's median 12-month price target for Corteva Inc is $87.00, about 6.5% above its May 4 closing price of $81.69

• The stock recently traded at 22 times the next 12-month earnings vs. a P/E of 20 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.